Skip to content

RemyDerm

Active Private limited companyfounded 2022active for 4 yearsBaron August de Becker-Remyplein 47/49, 3010 LeuvenKBO/BCE: BE 0787.206.864

Lifetime

4 annual accounts with figures on one time axis
peak of €132,266 in 2025
€132,266▲ €134,211
lowest -€177,452 in 2024
€27,348▲ €204,800
peak of €48,727 in 2022
-€198,284▲ €27,348
€1.6m▼ 3.9%
Board4 names since 2022
4 directors and 3 others
Documentsfilings and deeds
24-07-20267 days before the deadline
2025micro format
Gross margin from -€1,945 to €132,266Profit of €27,348, after a loss appointed as director 08-04Equity from -€225,632 to -€198,284Investments €123,896Cash from €138,559 to €11,829

Key points

from the 2025 annual accounts

Equity

-€198,284
2022202320242025

Debts exceed assets in financial year 2025.

Result

€27,348 €27,348
-€177,0002024€27,3002025

Back in profit in 2025, after a loss of €177,452 in 2024.

Turnover

≈ €330,000 estimated

The micro format states no turnover.

Debts

€1.6m 114% of the balance sheet
Financial debts 84%Suppliers 0%Other 16%

Of this, €260,277 falls due within a year.

Investments

€123,896 3.5 times depreciation
2022202320242025

Green is investment, beige is depreciation. Land and buildings stand 107.1% higher than in 2024.

Filings

4 annual accounts since 2022
AprilJune31 JulyOctober2022202320242025

The last four annual accounts were filed 7 to 21 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 262 companies had the same profile as RemyDerm has now. Each dot is one company, two years later.

97.3%
were still trading
0.8%
stopped another way
1.1%
went bankrupt
  • Small
  • 2 to 5 years old
  • negative equity
  • a profit under 5% of the balance sheet

Another 0.8% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 262 companies, not a prediction for RemyDerm. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 13-06-2022
Director, since 13-06-2022
Director
Director, since 01-03-2025
  • 1,680 sharesdeed of 15-06-2022
  • 1,680 sharesdeed of 15-06-2022
  • 1,680 sharesdeed of 15-06-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0787206864
appointed as director General meeting of 01-03-2025 · Gazette deed
Incorporation Founding capital of €166,320, 5,040 shares · Founded by , and · , and appointed · published on 15-06-2022 · Gazette deed
First establishment Baron August de Becker-Remyplein 47/49, Leuven
All 10 events

Official details

Source: KBO
Status
Active since 13-06-2022Normal situation
Activity
Buying and selling of own real estateNACE 68110and 2 others3 activities on the establishment unitFrom the articles, 6 activities
Establishment unit
2.332.904.5373010 Leuven, since 13-06-2022
Financial year end
31 December
Peppol
Reachable since 02-09-2025
Company details

Annual accounts 2025

€1.4m▼ 2.6%
Filing
Filed on 24-07-2026, 7 days before the end of the filing period
Financials

Insights on RemyDerm

RemyDerm files the micro format. That format states no turnover. The gross margin rose from -€20,917 in 2022 to €132,266 in 2025.

The balance sheet grew most in 2024 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about RemyDerm

What is the company number of RemyDerm?
The company number of RemyDerm is 0787.206.864. The VAT number is the same number with BE in front: BE 0787.206.864.
Where is RemyDerm based?
The registered office is at Baron August de Becker-Remyplein 47/49, 3010 Leuven.Company details
What does RemyDerm do?
According to the KBO register, the main activity of the establishment unit is buying and selling of own real estate (NACE 68110). The KBO lists 2 more.
What is the legal form of RemyDerm?
RemyDerm is a private limited company (BV).
When was RemyDerm founded?
RemyDerm was founded on 13-06-2022.
Is RemyDerm still active?
Yes, RemyDerm is an active enterprise in the KBO register.
What is the turnover of RemyDerm?
The turnover in financial year 2025 is about €330,000. This figure is estimated from the gross margin of €132,266 and 2,458 comparable companies of the same size. It probably lies between €220,000 and €510,000. It is a rough estimate.Financials
Is RemyDerm profitable?
In financial year 2025, RemyDerm made a profit of €27,348.
Where can I find the annual accounts of RemyDerm?
RemyDerm filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of RemyDerm due?
RemyDerm must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.